tesidolumab (LFG316) / Novartis, MorphoSys 
Welcome,         Profile    Billing    Logout  
 10 Diseases   1 Trial   1 Trial   154 News 

Disease Category View   Disease View
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 012345678910
            
                                                                                                      
            
Atrophy           
          
            
            
Choroidal Neovascularization           
          
            
            
Eye Diseases           
          
            
            
Geographic Atrophy           
          
            
            
Macular Degeneration           
          
            
            
Neovascularization, Pathologic           
          
            
            
Paroxysmal Nocturnal Hemoglobinuria           
          
            
            
Retinal Degeneration           
          
            
            
Retinal Diseases           
          
            
            
Uveitis